Medtronic Launch of MiniMed 780G System Integrated with Abbott Instinct Sensor

Published: 03 Dec 2025

Author: Precedence Research

Share :

Medtronic, a top international company in the field of healthcare technology, officially announced the introduction of the MiniMedtm 780G system. This product is also equipped with the Abbott sensor called Instinct in the U.S. The system is commercially released, and this is a key innovative step in the sphere of diabetes management technologies after its clearance by the FDA earlier this year. This launch marks a significant step in Medtronic's efforts to simplify diabetes management and improve the quality of life for individuals with diabetes.

The Instinct sensor is the smallest and thinnest CGM sensor in the world, invented by Abbott, and can be worn for a period of 15 days. The sensor and MiniMedtm 780G system give very accurate real-time glucose readings. Therefore, the system automatically regulates an insulin dosage every five minutes. Real-time automation allows the participant to lessen the stress of manual insulin maintenance and devote more time to their everyday living with a sense of confidence, and reduce the number of concerns.

The introduction also supports the agenda of Medtronic to deliver a multi-purpose and individualized diabetes management ecosystem. The sensors offer unique benefits and integration with the MiniMedtm 780G system also guarantees users a configuration that best fits their lifestyle, treatment objectives, and preferences. This adaptability removes various issues impacting the diabetes community and also emphasizes the fact that Medtronic is dedicated to patient-centric innovation. Furthermore, the commercial launch is an expression of the bigger scope of Medtronic that aims to establish a fully automated, smart ecosystem for diabetes.

Executive Statements

Que Dallara, EVP and President, Medtronic Diabetes

“This milestone marks an important next step in our work to bring the proven clinical outcomes of our MiniMe 780G system to more people living with diabetes. With this launch, we’re expanding a smart dosing ecosystem built for choice, so every person can find a solution that fits their life. We exist to make life with diabetes easier and more predictable, allowing people to enjoy greater freedom and better health every day. Our goal is to deliver confidence and peace of mind so everyone including loved ones can live boldly without compromise.”

Dr. Steve Edelman, TCOYD Founder

“Bringing together the Instinct sensor, made by Abbott, with the MiniMed 780G algorithm creates an extremely effective combination. Feedback from the early customer pilot program has been very positive, and patients have seen improved time-in-range and a more seamless diabetes management experience. I’m thrilled that the Instinct sensor is now available, so more people living with type 1 diabetes can access this life-changing technology.”